Hunan Er Kang Pharmaceutical (300267) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.034x

Based on the latest financial reports, Hunan Er Kang Pharmaceutical (300267) has a cash flow conversion efficiency ratio of 0.034x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.55 Million ≈ $25.54 Million USD) by net assets (CN¥5.09 Billion ≈ $745.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300267 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Hunan Er Kang Pharmaceutical - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hunan Er Kang Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Er Kang Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Er Kang Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Grupo Herdez S.A.B. de C.V MX:HERDEZ	0.020x
MAP Aktif Adiperkasa Tbk PT JK:MAPA	0.093x
Hunan Changgao High Voltage Switchgear Group Co Ltd SHE:002452	0.057x
Altri SGPS SA LS:ALTR	0.074x
Axis Real Estate Investment Trust KLSE:5106	0.012x
Ningbo Donly Co Ltd SHE:002164	0.025x
Alarko Holding AS IS:ALARK	0.016x
Global Infotech Co Ltd SHE:300465	0.360x

Annual Cash Flow Conversion Efficiency for Hunan Er Kang Pharmaceutical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Hunan Er Kang Pharmaceutical market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $644.18 Million	CN¥166.69 Million ≈ $24.39 Million	0.038x	+22.71%
2023-12-31	CN¥4.81 Billion ≈ $703.86 Million	CN¥148.42 Million ≈ $21.72 Million	0.031x	-44.54%
2022-12-31	CN¥5.05 Billion ≈ $739.13 Million	CN¥281.02 Million ≈ $41.12 Million	0.056x	+192.56%
2021-12-31	CN¥4.87 Billion ≈ $713.18 Million	CN¥92.68 Million ≈ $13.56 Million	0.019x	-38.29%
2020-12-31	CN¥5.79 Billion ≈ $847.78 Million	CN¥178.53 Million ≈ $26.12 Million	0.031x	-59.96%
2019-12-31	CN¥5.79 Billion ≈ $847.71 Million	CN¥445.82 Million ≈ $65.24 Million	0.077x	+250.28%
2018-12-31	CN¥5.64 Billion ≈ $825.21 Million	CN¥123.89 Million ≈ $18.13 Million	0.022x	-82.75%
2017-12-31	CN¥5.41 Billion ≈ $791.90 Million	CN¥689.11 Million ≈ $100.84 Million	0.127x	+37.27%
2016-12-31	CN¥5.24 Billion ≈ $767.41 Million	CN¥486.50 Million ≈ $71.19 Million	0.093x	-23.90%
2015-12-31	CN¥4.26 Billion ≈ $622.97 Million	CN¥518.96 Million ≈ $75.94 Million	0.122x	+16.62%
2014-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥175.38 Million ≈ $25.66 Million	0.105x	-19.97%
2013-12-31	CN¥1.33 Billion ≈ $195.21 Million	CN¥174.22 Million ≈ $25.49 Million	0.131x	+80.97%
2012-12-31	CN¥1.16 Billion ≈ $170.37 Million	CN¥84.02 Million ≈ $12.30 Million	0.072x	+1.24%
2011-12-31	CN¥1.06 Billion ≈ $155.44 Million	CN¥75.72 Million ≈ $11.08 Million	0.071x	-70.36%
2010-12-31	CN¥176.62 Million ≈ $25.85 Million	CN¥42.47 Million ≈ $6.21 Million	0.240x	+159.86%
2009-12-31	CN¥110.01 Million ≈ $16.10 Million	CN¥10.18 Million ≈ $1.49 Million	0.093x	+2663.24%
2008-12-31	CN¥63.01 Million ≈ $9.22 Million	CN¥211.00K ≈ $30.88K	0.003x	--

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.00 Billion

CN¥6.85 Billion CNY

Market Cap Rank

#9054 Global

#2291 in China

Share Price

CN¥3.32

Change (1 day)

-2.92%

52-Week Range

CN¥3.03 - CN¥4.84

All Time High

CN¥17.60